..Follow up studies with safety monitoring, regulatory oversight and objective outcome measures will be required to definitively assess safety and efficacy for this novel class of potential immunological therapies in multiple sclerosis...

J O FlemingDepartment of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USAMult Scler 17:743-54. 2011

..Probiotic treatment strategy based on the hygiene hypothesis, such as administration of ova from the non-pathogenic helminth, Trichuris suis, (TSO) has proven safe and effective in autoimmune inflammatory bowel disease...